日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prolonged TNF-α stimulation induces a PD-1-associated exhaustion-like phenotype in mesenchymal stromal cells

长期TNF-α刺激可诱导间充质基质细胞产生PD-1相关的衰竭样表型。

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2026.1680076
Matsunaga, Naoya; Akiyama, Kentaro; Mun, Aung Ye; Zou, Tinling; Ito, Kazuki; Tagashira, Ruji; Kuboki, Takuo
基质细胞
细胞生物学
TNF-α
PD-1
发表日期：2026
文献求助 收藏

Correction to: Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology

更正：日本临床肿瘤学会核医学治疗促进工作组提出的《2025年日本核医学治疗促进政策建议》

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02925-9
Suzuki, Kotaro; Miyake, Hideaki; Inaki, Anri; Takano, Shoko; Kuboki, Yasutoshi; Mizowaki, Takashi; Nakamura, Katsumasa; Ueno, Makoto; Matsumoto, Shigemi; Obinata, Daisuke; Nakagawa, Tohru; Murakami, Masato; Majima, Yoshiyuki; Yokono, Megumu; Namba, Masao; Yoshino, Takayuki
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Experimental Analysis of Automatic Discrimination Performance Between Simulated Bruxism and Non-Bruxism Under Conscious Conditions Using Electromyography and Machine Learning

利用肌电图和机器学习技术对意识状态下模拟磨牙和非磨牙的自动区分性能进行实验分析

期刊:International Journal of Dentistry
影响因子:2.2
doi:10.1155/ijod/7874254
Minakuchi, Hajime; Nagasaki, Mitsuhiro; Đình, Lộc Hoàng; Miki, Haruna; Omori, Ko; Nishimura, Tazuko; Kuboki, Takuo; Minematsu, Nobuaki
发表日期：2026
文献求助 收藏

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer

Claudin 18.2 表达对 HER2 阳性胃癌或胃食管交界处癌患者曲妥珠单抗疗效的影响

期刊:
影响因子:
doi:10.1016/j.esmogo.2025.100300
Okemoto, D; Nakayama, I; Jubashi, A; Sakamoto, N; Okunaka, M; Matsubara, Y; Miyashita, Y; Kobayashi, A; Okazaki, U; Yamamoto, K; Seguchi, K; Hosokai, T; Ogura, T; Mishima, S; Kotani, D; Kawazoe, A; Hashimoto, T; Kuboki, Y; Bando, H; Kojima, T; Yoshino, T; Kuwata, T; Yamaguchi, T; Nishikawa, H; Shitara, K
胃癌
肿瘤
肿瘤免疫
HER2
发表日期：2026
文献求助 收藏

Phase I Dose-Escalation Results for the Delta-Like Ligand 3/CD3 IgG-Like T-Cell Engager Obrixtamig (BI 764532) in Patients With Delta-Like Ligand 3+ Small Cell Lung Cancer or Neuroendocrine Carcinomas

Delta样配体3/CD3 IgG样T细胞衔接剂Obrixtamig（BI 764532）在Delta样配体3+小细胞肺癌或神经内分泌癌患者中的I期剂量递增结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00363
Wermke, Martin; Gambardella, Valentina; Kuboki, Yasutoshi; Felip, Enriqueta; Sanmamed, Miguel F; Alese, Olatunji B; Sayehli, Cyrus M; Arriola, Edurne; Wolf, Jürgen; Villaruz, Liza C; Bertulis, Julia; Studeny, Matus; Bouzaggou, Mohamed; Fang, Xiaoyan; Morgensztern, Daniel
肺癌
肿瘤
T细胞
肿瘤免疫
CD3
IgG
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer

索托拉西布联合帕尼单抗与研究者选择的方案治疗化疗难治性KRAS G12C突变型结直肠癌的III期CodeBreakK 300研究的总生存期分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-02026
Pietrantonio, Filippo; Salvatore, Lisa; Esaki, Taito; Modest, Dominik Paul; Lopez-Bravo, David Paez; Taieb, Julien; Karamouzis, Michalis V; Ruiz-Garcia, Erika; Kim, Tae Won; Kuboki, Yasutoshi; Meriggi, Fausto; Cunningham, David; Yeh, Kun-Huei; Chan, Emily; Chao, Joseph; Tran, Qui; Cremolini, Chiara; Fakih, Marwan
RAS
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Synthesis of Low-Molecular-Weight Fucoidan Analogue and Its Inhibitory Activities against Heparanase and SARS-CoV-2 Infection

低分子量岩藻聚糖类似物的合成及其对肝素酶和SARS-CoV-2感染的抑制活性

期刊:Angewandte Chemie-International Edition
影响因子:16.9
doi:10.1002/anie.202411760
Sugimoto, Aoi; Koike, Tatsuki; Kuboki, Yuya; Komaba, Sumika; Kosono, Shuhei; Aswathy, Maniyamma; Anzai, Itsuki; Watanabe, Tokiko; Toshima, Kazunobu; Takahashi, Daisuke
SARS-CoV-2
炎症/感染
发表日期：2025
文献求助 收藏

Clinical characterization of FGFR2b expression in patients with advanced gastric or gastroesophageal junction adenocarcinoma

晚期胃癌或胃食管交界处腺癌患者中FGFR2b表达的临床特征

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105322
Sato, S; Rhodes, S L; Aoki, Y; Nakayama, I; Hashimoto, T; Hawkins, J; Yanes, R E; Chang, C-H; Nakamura, Y; Kawazoe, A; Mishima, S; Kotani, D; Kuboki, Y; Bando, H; Kojima, T; Yoshino, S; Reading, S; Honeycutt, H; Finger, E; Endo, I; Sakamoto, N; Kuwata, T; Yoshino, T; Shitara, K
胃癌
肿瘤
FGFR2
肿瘤免疫
发表日期：2025
文献求助 收藏

Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer

CLDN18.2阳性胃癌患者接受含佐贝妥昔单抗化疗期间早期胃炎的特征分析

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105805
Yamamoto, K; Owaki, Y; Nakayama, I; Sakamoto, N; Ishizaka, M; Kadota, T; Okemoto, D; Matsubara, Y; Miyashita, Y; Kobayashi, A; Okazaki, U; Seguchi, K; Hosokai, T; Ogura, T; Mishima, S; Kotani, D; Kawazoe, A; Hashimoto, T; Kuboki, Y; Bando, H; Kojima, T; Yoshino, T; Kuwata, T; Ishii, G; Yano, T; Shitara, K
胃癌
CLDN1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase II trial of enfortumab vedotin in patients with previously treated gastric and esophageal cancers

恩福妥单抗治疗既往接受过治疗的胃癌和食管癌患者的II期临床试验

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105806
Muro, K; Chin, K; Maron, S B; Braiteh, F S; Mitani, S; Hara, H; Kuboki, Y; Mulcahy, M F; Baranda, J C; Gardner, F P; Jin, N; Hamauchi, S; Kaplan, J; Gorla, S; Liu, S; Wozniak, M; Poondru, S; Dillon, R; Meng, C; Kondo, S
胃癌
食管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏